Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess - Chan, JL; Bullen, J; Stoyneva, V (J Clin Endocrinol Metab, 2005)
et al.